The Asia-Pacific Antiviral Drugs Market is expected to reach USD 7.46 billion by 2021 from USD 5.54 billion in 2016, growing at a CAGR of 6.12% during the forecast period, 2016-2021.
Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections. Asia-Pacific is one of the emerging region for Antiviral Drugs.
Browse market data tables and in-depth TOC of the Asia-Pacific Antiviral Drugs Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/
The growth of Antiviral drugs in Asia-Pacific market is majorly driven by factors such as increased public awareness, rise in healthcare expenditure, introduction of new and innovative products, and increase in viral infection incidences. In addition, increasing diseased population and rising demand for antiviral drugs are further stimulating the antiviral drugs market. The key restraints of the market are high cost involved in drug development and increase in demand for alternative medicines such as naturopathy, homeopathy, and oriental medicines among others. Majority of population, especially in India and China rely on traditional medicines for treating flu like cold, cough and viral fever.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/request-sample
Asia-Pacific Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers. The Asia-Pacific market is geographically segmented into China, India, Japan, South Korea and Australia.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-antiviral-drugs-market-1590/inquire
The major companies dominating the Antiviral Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
